IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that Kirk Kaminsky will be the new president of McKesson’s U.S. Pharmaceutical and Specialty Solutions (USPSS) business. Kaminsky will assume the role effective immediately, reporting to CEO Brian Tyler.
Kaminsky currently serves as president of McKesson Specialty Provider Organization, a division of USPSS, where he leads a team responsible for a broad suite of provider solutions. These include drug purchasing, clinical and operational software and analytics, practice management services and clinical trials across the McKesson Specialty Provider base, including The US Oncology Network.
“Kirk is a special leader, versed in both strategy and operational excellence. He understands the complexities of the healthcare landscape — and our customers’ needs — inside and out. He’s incredibly patient-focused and a terrific people leader,” said Tyler. “His vision, experience and leadership will help us continue to serve our customers and business partners while expanding our service offerings and market leadership.”
Kaminsky has been a McKesson executive since 2003, when he joined the company’s Corporate Strategy and Business Development group. Since then, he ran the U.S. Pharmaceutical packaging business and has been integral to the company’s growing presence in the oncology space. He served as president of The US Oncology Network and was responsible for its financial and operational support; he also led the overall strategy in support of The Network’s vision of improving patient outcomes and quality of life, and advancing the future of cancer treatment by taking a leadership role in value-based care.
“I’m very excited about this opportunity,” Kaminsky said. “McKesson’s set of strategic assets positions us well to drive meaningful value across the healthcare ecosystem. I’m also humbled and honored to lead this team. This team of professionals is dedicated to operational excellence, working with integrity and accountability and meeting our customers’ needs.”
Prior to McKesson, Kaminsky was with Bank One Corporation, where he was responsible for setting and executing payment strategies across the commercial and retail bank. He also spent a few years in investment banking as a financial analyst, concentrating on corporate finance for healthcare and consumer retail.
Kaminsky received an MBA from The Wharton School and a BA in Economics for Business from Occidental College.
About McKesson Corporation
McKesson Corporation, currently ranked 6th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.
